XBRANE - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79253207
Serial Number
79253207
Registration Number
6004520
Word Mark
XBRANE
Status
700 - Registered
Status Date
2020-03-10
Filing Date
2018-11-12
Registration Number
6004520
Registration Date
2020-03-10
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form Typeset
Published for Opposition Date
2019-12-24
Attorney Name
Andy I. Corea
Law Office Assigned Location Code
M80
Employee Name
GARDNER, DAWNA BERYL
Statements
Indication of Colors claimed
The color(s) dark blue and light blue is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the stylized light blue and dark blue wording "XBRANE".
Goods and Services
Pharmaceutical preparations and medical preparations all for treating cancer, endometriosis, myoma, eye diseases, age related macular degeneration, skin diseases, precocious puberty, vascular diseases, cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, autoimmune diseases, angiogenesis diseases and disorders, genetic conditions, infectious diseases, ocular diseases and disorders, inflammatory diseases and disorders, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, ulcerative colitis, diabetes, diabetic macular edema, diabetic related retinopathy, multiple sclerosis, arthritis, osteoporosis, bone metastasis; generic pharmaceutical preparations and biological pharmaceutical preparations all for treating cancer, endometriosis, myoma, eye diseases, age related macular degeneration, skin diseases, precocious puberty, vascular diseases, cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, autoimmune diseases, angiogenesis diseases and disorders, genetic conditions and infectious diseases; generic pharmaceutical preparations and biological pharmaceutical preparations all for treating ocular diseases and disorders, inflammatory diseases and disorders, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, ulcerative colitis, diabetes, diabetic macular edema, diabetic related retinopathy, multiple sclerosis, arthritis, osteoporosis, bone metastasis; chemotherapeutics; hormones for medical purposes; pharmaceutical agents for treating metabolic disorders; amino acids for medical purposes; pharmaceutical agents for treating immunity disorders; pharmaceutical agents for treating physically caused lesions; antiviral preparations; diagnostic kits consisting primarily of monoclonal antibodies for the diagnosis, treatment and prevention of cancer, endometriosis, myoma, eye diseases, age related macular degeneration, skin diseases, precocious puberty, vascular diseases, cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, autoimmune diseases, angiogenesis diseases and disorders, genetic conditions, infectious diseases; diagnostic kits consisting primarily of monoclonal antibodies for the diagnosis, treatment and prevention of ocular diseases and disorders, inflammatory diseases and disorders, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, ulcerative colitis, diabetes, diabetic macular edema, diabetic related retinopathy, multiple sclerosis, arthritis, osteoporosis and bone metastasis
Goods and Services
Surgical apparatus and instruments; injection device for pharmaceuticals; injection syringes; injection needles; medical apparatus, namely, automatic infusion and injection devices for administering drugs to humans
Goods and Services
Scientific and medical research and development; pharmaceutical research and development services; research and development services in the fields of biological similar pharmaceuticals, generic drugs, biotechnology, diagnostics and pharmaceuticals; consultancy services relating to the discovery and evaluation of drugs and chemical compounds having diagnostic properties and therapeutic properties; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment; diagnostic services in the field of troubleshooting biotechnology and pharmaceutical equipment for scientific research purposes; analyzing biotechnology and pharmaceutical equipment for scientific research purposes; development of new technology for others in the field of biotechnology; medical, pharmaceutical and biotechnological laboratory research services; information, consultancy and advisory services relating to scientific and medical research and development, biotechnological and pharmaceutical research and development and medical equipment research and development
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-03-05
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2019-03-05
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-03-05
Primary Code
042
Current Trademark Owners
Party Name
Xbrane Biopharma AB
Party Type
30 - Original Registrant
Legal Entity Type
09 - Joint Stock Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Xbrane Biopharma AB
Party Type
30 - Original Registrant
Legal Entity Type
09 - Joint Stock Company
Address
Please log in with your Justia account to see this address.
Party Name
Xbrane Biopharma AB
Party Type
20 - Owner at Publication
Legal Entity Type
09 - Joint Stock Company
Address
Please log in with your Justia account to see this address.
Party Name
Xbrane Biopharma AB
Party Type
10 - Original Applicant
Legal Entity Type
09 - Joint Stock Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Andy I. Corea
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1452995
International Registration Date
2018-11-12
International Publication Date
2019-02-28
International Renewal Date
2028-11-12
Auto Protection Date
2020-08-28
International Status
001 - Request for extension of protection established
International Status Date
2019-02-28
Priority Claimed In
True
Priority Claimed Date
2018-06-13
First Refusal In
True
Trademark Events
Event DateEvent Description
2019-02-28SN ASSIGNED FOR SECT 66A APPL FROM IB
2019-03-05NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-03-05ASSIGNED TO EXAMINER
2019-03-07NON-FINAL ACTION WRITTEN
2019-03-08NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2019-03-09APPLICATION FILING RECEIPT MAILED
2019-03-20REFUSAL PROCESSED BY MPU
2019-03-20NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2019-04-06REFUSAL PROCESSED BY IB
2019-06-12TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-06-12CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-06-12TEAS/EMAIL CORRESPONDENCE ENTERED
2019-07-09FINAL REFUSAL WRITTEN
2019-07-09FINAL REFUSAL E-MAILED
2019-07-09NOTIFICATION OF FINAL REFUSAL EMAILED
2019-11-07TEAS REQUEST FOR RECONSIDERATION RECEIVED
2019-11-07CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-11-07TEAS/EMAIL CORRESPONDENCE ENTERED
2019-11-15APPROVED FOR PUB - PRINCIPAL REGISTER
2019-11-19ASSIGNED TO LIE
2019-12-04NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-12-18NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2019-12-18NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2019-12-24PUBLISHED FOR OPPOSITION
2019-12-24OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-01-03NOTIFICATION PROCESSED BY IB
2020-03-10REGISTERED-PRINCIPAL REGISTER
2020-06-10FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2020-07-11FINAL DISPOSITION PROCESSED
2020-07-11FINAL DISPOSITION NOTICE SENT TO IB
2020-07-31FINAL DECISION TRANSACTION PROCESSED BY IB